EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtOpen Access · CC BY 4.0

Skull-Base Plasmacytomas: A Systematic Review on Therapeutic Trends

Francisco Call-Orellana iD, Kishore Balasubramanian iD, Hanyu Qiu iD, Alexander Houpt, Tushar Kanti Bhadra iD, Georgios Toumbas iD, Beste Gülsuna, Jeffrey Zuccato, Panayiotis Pelargos, Abdul Basit Khan, Hakeem J Shakir iD

Cancers · 04.08.2026 · 18 (15) · 2495

DOI: 10.3390/cancers18152495 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 04.08.2026. Verfasst von Francisco Call-Orellana und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030, USA. Die Arbeit nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Skull base plasmacytomas are rare plasma cell neoplasms arising from the clivus, sphenoid bone, and petrous apex, presenting with cranial neuropathies and bearing a high risk of progression to multiple myeloma. Optimal management remains poorly defined due to their rarity.

Objective

The objectives of this study are to comprehensively characterize the clinical presentation, management strategies, and outcomes of skull base plasmacytomas and identify evolving trends in the literature.

Methods

A systematic search of PubMed, EMBASE, Web of Science, and Cochrane databases was conducted, yielding 92 studies (18 case series and 74 case reports) encompassing 118 patients. Data on the demographics, symptoms, imaging, histopathology, treatment, and outcomes were extracted and analyzed.

Results

The median patient age was 56 years; visual disturbances (66.1%) and headache (54.2%) were the most common presenting symptoms. The middle and posterior cranial fossae were most frequently involved, and cranial nerve VI was most affected (65.7%). Surgical resection was performed in 63.6% of cases with a gross total resection in 36%. At a median follow-up of 12 months (calculated across the entire cohort of 118 patients, including the 29 who presented with a prior diagnosis of multiple myeloma), 81.4% were alive, with symptom resolution at 38.1% or improvement at 26.2%. Recurrence occurred in 19.4% of patients, and multiple myeloma developed in 25.8% of patients without a prior diagnosis. Multiple myeloma status was the only independent predictor of survival on multivariate analysis (OR = 10.14, 95% CI: 1.63–63.04, p = 0.013).

Conclusions

Skull base plasmacytomas show consistent clinical patterns but variable management strategies. Surgery is increasingly utilized; yet, its survival benefit remains unclear. Prospective multicenter studies with standardized outcome reporting and molecular profiling are needed to optimize individualized care.

Schlagwörter

Stichwörter der Autor:innen

plasmacytomaskull basesystematic review

Autor:innen und Institutionen

  • Department of Neurosurgery, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030, USA.
  • College of Medicine, Texas A&M Health Science Center, Houston, TX 77807, USA.
  • Department of Neurosurgery, University of Oklahoma College of Medicine, Oklahoma City, OK 73104, USA.
  • Department of Cardiovascular and Thoracic Surgery, National Institute of Cardiovascular Diseases, Dhaka 1207, Bangladesh.
  • Clinical School of Medicine, University of Cambridge, Cambridge CB2 0SP, UK.

ORCID-Profile: Francisco Call-Orellana, Kishore Balasubramanian, Hanyu Qiu, Tushar Kanti Bhadra, Georgios Toumbas, Hakeem J Shakir

Zitieren

APA

Call-Orellana, F., Balasubramanian, K., Qiu, H., Houpt, A., Bhadra, T. K., Toumbas, G., Gülsuna, B., Zuccato, J., Pelargos, P., Khan, A. B., & Shakir, H. J. (2026). Skull-Base Plasmacytomas: A Systematic Review on Therapeutic Trends. Cancers, 18(15), 2495. https://doi.org/10.3390/cancers18152495

Vancouver

Call-Orellana F, Balasubramanian K, Qiu H, Houpt A, Bhadra TK, Toumbas G, et al. Skull-Base Plasmacytomas: A Systematic Review on Therapeutic Trends. Cancers. 2026;18(15):2495. doi:10.3390/cancers18152495

BibTeX
@article{CallOrellana2026,
  author = {Call-Orellana, Francisco and Balasubramanian, Kishore and Qiu, Hanyu and Houpt, Alexander and Bhadra, Tushar Kanti and Toumbas, Georgios and Gülsuna, Beste and Zuccato, Jeffrey and Pelargos, Panayiotis and Khan, Abdul Basit and Shakir, Hakeem J},
  title = {Skull-Base Plasmacytomas: A Systematic Review on Therapeutic Trends},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {15},
  pages = {2495},
  doi = {10.3390/cancers18152495}
}
Kostenlos starten →